Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2019

Open Access 01-12-2019 | Research

Measurement of health-related quality by multimorbidity groups in primary health care

Authors: Magdalena Millá-Perseguer, Natividad Guadalajara-Olmeda, David Vivas-Consuelo, Ruth Usó-Talamantes

Published in: Health and Quality of Life Outcomes | Issue 1/2019

Login to get access

Abstract

Background

Increased life expectancy in Western societies does not necessarily mean better quality of life. To improve resources management, management systems have been set up in health systems to stratify patients according to morbidity, such as Clinical Risk Groups (CRG). The main objective of this study was to evaluate the effect of multimorbidity on health-related quality of life (HRQL) in primary care.

Methods

An observational cross-sectional study, based on a representative random sample (n = 306) of adults from a health district (N = 32,667) in east Spain (Valencian Community), was conducted in 2013. Multimorbidity was measured by stratifying the population with the CRG system into nine mean health statuses (MHS). HRQL was assessed by EQ-5D dimensions and the EQ Visual Analogue Scale (EQ VAS). The effect of the CRG system, age and gender on the utility value and VAS was analysed by multiple linear regression. A predictive analysis was run by binary logistic regression with all the sample groups classified according to the CRG system into the five HRQL dimensions by taking the “healthy” group as a reference. Multivariate logistic regression studied the joint influence of the nine CRG system MHS, age and gender on the five EQ-5D dimensions.

Results

Of the 306 subjects, 165 were female (mean age of 53). The most affected dimension was pain/discomfort (53%), followed by anxiety/depression (42%). The EQ-5D utility value and EQ VAS progressively lowered for the MHS with higher morbidity, except for MHS 6, more affected in the five dimensions, save self-care, which exceeded MHS 7 patients who were older, and MHS 8 and 9 patients, whose condition was more serious. The CRG system alone was the variable that best explained health problems in HRQL with 17%, which rose to 21% when associated with female gender. Age explained only 4%.

Conclusions

This work demonstrates that the multimorbidity groups obtained by the CRG classification system can be used as an overall indicator of HRQL. These utility values can be employed for health policy decisions based on cost-effectiveness to estimate incremental quality-adjusted life years (QALY) with routinely e-health data.
Patients under 65 years with multimorbidity perceived worse HRQL than older patients or disease severity. Knowledge of multimorbidity with a stronger impact can help primary healthcare doctors to pay attention to these population groups.
Literature
1.
go back to reference Ministerio de Sanidad SS, Igualdad e. Indicadores de Salud 2013. Evolución de los indicadores del estado de salud en España y su magnitud en el contexto de la Unión Europea. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2014. Ministerio de Sanidad SS, Igualdad e. Indicadores de Salud 2013. Evolución de los indicadores del estado de salud en España y su magnitud en el contexto de la Unión Europea. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2014.
2.
go back to reference OECD/EU: Health at a Glance: Europe 2016 – State of Health in the EU Cycle, OECD Publishing, Paris. In.; 2016. OECD/EU: Health at a Glance: Europe 2016 – State of Health in the EU Cycle, OECD Publishing, Paris. In.; 2016.
3.
go back to reference WHO: Disability and health. In. Edited by WHO; 2017. WHO: Disability and health. In. Edited by WHO; 2017.
4.
go back to reference Nicholson K, Makovski TT, Griffith LE, Raina P, Stranges S, van den Akker M. Multimorbidity and comorbidity revisited: refining the concepts for international health research. J Clin Epidemiol. 2018. Nicholson K, Makovski TT, Griffith LE, Raina P, Stranges S, van den Akker M. Multimorbidity and comorbidity revisited: refining the concepts for international health research. J Clin Epidemiol. 2018.
5.
go back to reference Palmer K, Marengoni A, Forjaz MJ, Jureviciene E, Laatikainen T, Mammarella F, Muth C, Navickas R, Prados-Torres A, Rijken M, et al. Multimorbidity care model: recommendations from the consensus meeting of the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS). Health Policy. 2018;122(1):4–11.CrossRef Palmer K, Marengoni A, Forjaz MJ, Jureviciene E, Laatikainen T, Mammarella F, Muth C, Navickas R, Prados-Torres A, Rijken M, et al. Multimorbidity care model: recommendations from the consensus meeting of the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS). Health Policy. 2018;122(1):4–11.CrossRef
6.
go back to reference WHO: Innovative Care for Chronic Conditions. Building blocks for action. In.: WHO; 2014. WHO: Innovative Care for Chronic Conditions. Building blocks for action. In.: WHO; 2014.
7.
go back to reference Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005;3(3):223–8.CrossRef Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005;3(3):223–8.CrossRef
8.
go back to reference Inoriza JM, Coderch J, Carreras M, Vall-Llosera L, Garcia-Goni M, Lisbona JM, Ibern P. Measurement of morbidity attended in an integrated health care organization. Gac Sanit. 2009;23(1):29–37.CrossRef Inoriza JM, Coderch J, Carreras M, Vall-Llosera L, Garcia-Goni M, Lisbona JM, Ibern P. Measurement of morbidity attended in an integrated health care organization. Gac Sanit. 2009;23(1):29–37.CrossRef
9.
go back to reference Hunger M, Thorand B, Schunk M, Döring A, Menn P, Peters A, Holle R. Multimorbidity and health-related quality of life in the older population: results from the German KORA-age study. Health Qual Life Outcomes. 2011;9:53.CrossRef Hunger M, Thorand B, Schunk M, Döring A, Menn P, Peters A, Holle R. Multimorbidity and health-related quality of life in the older population: results from the German KORA-age study. Health Qual Life Outcomes. 2011;9:53.CrossRef
10.
go back to reference de Miguel P, Caballero I, Rivas FJ, Manera J, de Vicente MA, Gómez Á. Morbidity observed in a health area: impact on professionals and funding. Aten Primaria. 2015;47(5):301–7.CrossRef de Miguel P, Caballero I, Rivas FJ, Manera J, de Vicente MA, Gómez Á. Morbidity observed in a health area: impact on professionals and funding. Aten Primaria. 2015;47(5):301–7.CrossRef
11.
go back to reference Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey. BMC Public Health. 2012;12:201.CrossRef Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey. BMC Public Health. 2012;12:201.CrossRef
12.
go back to reference Orueta JF, García-Álvarez A, García-Goñi M, Paolucci F, Nuño-Solinís R. Prevalence and costs of multimorbidity by deprivation levels in the Basque Country: a population based study using health administrative databases. PLoS One. 2014;9(2):e89787.CrossRef Orueta JF, García-Álvarez A, García-Goñi M, Paolucci F, Nuño-Solinís R. Prevalence and costs of multimorbidity by deprivation levels in the Basque Country: a population based study using health administrative databases. PLoS One. 2014;9(2):e89787.CrossRef
13.
go back to reference Mujica-Mota RE, Roberts M, Abel G, Elliott M, Lyratzopoulos G, Roland M, Campbell J. Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. Qual Life Res. 2015;24(4):909–18.CrossRef Mujica-Mota RE, Roberts M, Abel G, Elliott M, Lyratzopoulos G, Roland M, Campbell J. Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. Qual Life Res. 2015;24(4):909–18.CrossRef
14.
go back to reference Caballer Tarazona V, Guadalajara Olmeda N, Vivas Consuelo D, Clemente Collado A. Impact of morbidity on health care costs of a Department of Health through clinical risk groups. Valencian Community, Spain. Rev Esp Salud Publica. 2016;90:e1–e15.PubMed Caballer Tarazona V, Guadalajara Olmeda N, Vivas Consuelo D, Clemente Collado A. Impact of morbidity on health care costs of a Department of Health through clinical risk groups. Valencian Community, Spain. Rev Esp Salud Publica. 2016;90:e1–e15.PubMed
15.
go back to reference Calderon-Larranaga A, Abrams C, Poblador-Plou B, Weiner JP, Prados-Torres A. Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibration. BMC Health Serv Res. 2010;10:22.CrossRef Calderon-Larranaga A, Abrams C, Poblador-Plou B, Weiner JP, Prados-Torres A. Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibration. BMC Health Serv Res. 2010;10:22.CrossRef
16.
go back to reference Hughes JS, Averill RF, Eisenhandler J, Goldfield NI, Muldoon J, Neff JM, Gay JC. Clinical risk groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management. Med Care. 2004;42(1):81–90.CrossRef Hughes JS, Averill RF, Eisenhandler J, Goldfield NI, Muldoon J, Neff JM, Gay JC. Clinical risk groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management. Med Care. 2004;42(1):81–90.CrossRef
17.
go back to reference Vivas-Consuelo D, Uso-Talamantes R, Trillo-Mata JL, Caballer-Tarazona M, Barrachina-Martinez I, Buigues-Pastor L. Predictability of pharmaceutical spending in primary health services using clinical risk groups. Health Policy. 2014;116(2–3):188–95.CrossRef Vivas-Consuelo D, Uso-Talamantes R, Trillo-Mata JL, Caballer-Tarazona M, Barrachina-Martinez I, Buigues-Pastor L. Predictability of pharmaceutical spending in primary health services using clinical risk groups. Health Policy. 2014;116(2–3):188–95.CrossRef
18.
go back to reference Milla Perseguer M, Guadalajara Olmeda N, Vivas Consuelo D. Impact of cardiovascular risk factors on the consumption of resources in primary care according to clinical risk groups. Aten Primaria. 2018. Milla Perseguer M, Guadalajara Olmeda N, Vivas Consuelo D. Impact of cardiovascular risk factors on the consumption of resources in primary care according to clinical risk groups. Aten Primaria. 2018.
19.
go back to reference WHOQOL. The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998;46(12):1569–85.CrossRef WHOQOL. The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998;46(12):1569–85.CrossRef
20.
go back to reference Badia X, Carne X. The evaluation of quality of life in clinical trials. Medicina Clinica. 1998;110(14):550–6.PubMed Badia X, Carne X. The evaluation of quality of life in clinical trials. Medicina Clinica. 1998;110(14):550–6.PubMed
21.
go back to reference Revicki DA. Health-related quality of life in the evaluation of medical therapy for chronic illness. J Fam Pract. 1989;29(4):377–80.PubMed Revicki DA. Health-related quality of life in the evaluation of medical therapy for chronic illness. J Fam Pract. 1989;29(4):377–80.PubMed
22.
go back to reference Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Health-related quality of life and healthcare utilization in multimorbidity: results of a cross-sectional survey. Qual Life Res. 2013;22(4):791–9.CrossRef Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Health-related quality of life and healthcare utilization in multimorbidity: results of a cross-sectional survey. Qual Life Res. 2013;22(4):791–9.CrossRef
23.
go back to reference Romero M, Vivas-Consuelo D, Alvis-Guzman N. Is health related quality of life (HRQoL) a valid indicator for health systems evaluation? Springerplus. 2013;2:664.CrossRef Romero M, Vivas-Consuelo D, Alvis-Guzman N. Is health related quality of life (HRQoL) a valid indicator for health systems evaluation? Springerplus. 2013;2:664.CrossRef
24.
go back to reference Hanmer J, Feeny D, Fischhoff B, Hays RD, Hess R, Pilkonis PA, Revicki DA, Roberts MS, Tsevat J, Yu L. The PROMIS of QALYs. Health Qual Life Outcomes. 2015;13. Hanmer J, Feeny D, Fischhoff B, Hays RD, Hess R, Pilkonis PA, Revicki DA, Roberts MS, Tsevat J, Yu L. The PROMIS of QALYs. Health Qual Life Outcomes. 2015;13.
25.
go back to reference Herdman M, Badia X, Berra S. EuroQol-5D: a simple alternative for measuring health-related quality of life in primary care. Atencion primaria / Sociedad Espanola de Medicina de Familia y Comunitaria. 2001;28(6):425–30.CrossRef Herdman M, Badia X, Berra S. EuroQol-5D: a simple alternative for measuring health-related quality of life in primary care. Atencion primaria / Sociedad Espanola de Medicina de Familia y Comunitaria. 2001;28(6):425–30.CrossRef
26.
go back to reference EuroQol G. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(199–208). EuroQol G. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(199–208).
27.
go back to reference Agborsangaya CB, Lahtinen M, Cooke T, Johnson JA. Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population. Health Qual Life Outcomes. 2014;12:7.CrossRef Agborsangaya CB, Lahtinen M, Cooke T, Johnson JA. Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population. Health Qual Life Outcomes. 2014;12:7.CrossRef
28.
go back to reference Real Decreto Legislativo 8/2015, de 30 de octubre, por el que se aprueba el texto refundido de la Ley General de la Seguridad Social. In. «BOE» núm. 261, de 31/10/2015.: Ministerio de Empleo y Seguridad Social.; 2015. Real Decreto Legislativo 8/2015, de 30 de octubre, por el que se aprueba el texto refundido de la Ley General de la Seguridad Social. In. «BOE» núm. 261, de 31/10/2015.: Ministerio de Empleo y Seguridad Social.; 2015.
30.
go back to reference Ministry of Health and Social Policy: Encuesta Nacional de Salud. España 2011/12. Calidad de vida relacionada con la salud en adultos: EQ-5D-5L. Serie Informes monográficos n° 3. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2014. Ministry of Health and Social Policy: Encuesta Nacional de Salud. España 2011/12. Calidad de vida relacionada con la salud en adultos: EQ-5D-5L. Serie Informes monográficos n° 3. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2014.
31.
go back to reference Fortin M, Bravo G, Hudon C, Lapointe L, Almirall J, Dubois MF, Vanasse A. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res. 2006;15(1):83–91.CrossRef Fortin M, Bravo G, Hudon C, Lapointe L, Almirall J, Dubois MF, Vanasse A. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res. 2006;15(1):83–91.CrossRef
32.
go back to reference Fortin M, Dubois MF, Hudon C, Soubhi H, Almirall J. Multimorbidity and quality of life: a closer look. Health Qual Life Outcomes. 2007;5:52.CrossRef Fortin M, Dubois MF, Hudon C, Soubhi H, Almirall J. Multimorbidity and quality of life: a closer look. Health Qual Life Outcomes. 2007;5:52.CrossRef
33.
go back to reference Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11. Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11.
34.
go back to reference Peak J, Goranitis I, Day E, Copello A, Freemantle N, Frew E. Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP. Health Qual Life Outcomes. 2018;16(1):106.CrossRef Peak J, Goranitis I, Day E, Copello A, Freemantle N, Frew E. Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP. Health Qual Life Outcomes. 2018;16(1):106.CrossRef
35.
go back to reference Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell PM, Luengo-Fernandez R. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Mak. 2010;30. Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell PM, Luengo-Fernandez R. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Mak. 2010;30.
36.
go back to reference Argimon Pallás JM, Jiménez Villa J: Métodos de investigación clínica y epidemiológica, vol. Capítulo 15. Tamaño de la muestra; 2013. Argimon Pallás JM, Jiménez Villa J: Métodos de investigación clínica y epidemiológica, vol. Capítulo 15. Tamaño de la muestra; 2013.
37.
go back to reference Yepes-Núñez JJ, García García HI: Preferencias de estados de salud y medidas de utilidad. In., vol. 24. Iatreia; 2011: 365–377. Yepes-Núñez JJ, García García HI: Preferencias de estados de salud y medidas de utilidad. In., vol. 24. Iatreia; 2011: 365–377.
38.
go back to reference Attema AE, Edelaar-Peeters Y, Versteegh MM, Stolk EA. Time trade-off: one methodology, different methods. Eur J Health Econ. 2013;14(Suppl 1):S53–64.CrossRef Attema AE, Edelaar-Peeters Y, Versteegh MM, Stolk EA. Time trade-off: one methodology, different methods. Eur J Health Econ. 2013;14(Suppl 1):S53–64.CrossRef
39.
go back to reference Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Mak. 2001;21(1):7–16.CrossRef Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Mak. 2001;21(1):7–16.CrossRef
40.
go back to reference Garin N, Olaya B, Moneta MV, Miret M, Lobo A, Ayuso-Mateos JL, Haro JM. Impact of multimorbidity on disability and quality of life in the Spanish older population. PLoS One. 2014;9(11):e111498.CrossRef Garin N, Olaya B, Moneta MV, Miret M, Lobo A, Ayuso-Mateos JL, Haro JM. Impact of multimorbidity on disability and quality of life in the Spanish older population. PLoS One. 2014;9(11):e111498.CrossRef
41.
go back to reference Mielck A, Vogelmann M, Leidl R. Health-related quality of life and socioeconomic status: inequalities among adults with a chronic disease. Health Qual Life Outcomes. 2014;12:58.CrossRef Mielck A, Vogelmann M, Leidl R. Health-related quality of life and socioeconomic status: inequalities among adults with a chronic disease. Health Qual Life Outcomes. 2014;12:58.CrossRef
43.
go back to reference Sánchez Mollá M, Candela García I, Gómez-Romero FJ, Orozco Beltrán D, Ollero Baturone M. Concordance between stratification systems and identification of patients with multiple chronic diseases in primary care. Rev Calid Asist. 2017;32(1):10–6.CrossRef Sánchez Mollá M, Candela García I, Gómez-Romero FJ, Orozco Beltrán D, Ollero Baturone M. Concordance between stratification systems and identification of patients with multiple chronic diseases in primary care. Rev Calid Asist. 2017;32(1):10–6.CrossRef
44.
go back to reference Vivas-Consuelo D, Uso-Talamantes R, Guadalajara-Olmeda N, Trillo-Mata J-L, Sancho-Mestre C, Buigues-Pastor L. Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool. BMC Health Serv Res. 2014;14:462.CrossRef Vivas-Consuelo D, Uso-Talamantes R, Guadalajara-Olmeda N, Trillo-Mata J-L, Sancho-Mestre C, Buigues-Pastor L. Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool. BMC Health Serv Res. 2014;14:462.CrossRef
45.
go back to reference Coderch J, Sánchez-Pérez I, Ibern P, Carreras M, Pérez-Berruezo X, Inoriza JM. Predicting individual risk of high healthcare cost to identify complex chronic patients. Gac Sanit. 2014;28(4):292–300.CrossRef Coderch J, Sánchez-Pérez I, Ibern P, Carreras M, Pérez-Berruezo X, Inoriza JM. Predicting individual risk of high healthcare cost to identify complex chronic patients. Gac Sanit. 2014;28(4):292–300.CrossRef
46.
go back to reference Osca Guadalajara M, Guadalajara Olmeda N, Escartín Martínez R. Impact of Teriparatide on quality of life in osteoporotic patients. Rev Esp Salud Publica. 2015;89(2):215–25.CrossRef Osca Guadalajara M, Guadalajara Olmeda N, Escartín Martínez R. Impact of Teriparatide on quality of life in osteoporotic patients. Rev Esp Salud Publica. 2015;89(2):215–25.CrossRef
47.
go back to reference Prazeres F, Santiago L. Relationship between health-related quality of life, perceived family support and unmet health needs in adult patients with multimorbidity attending primary care in Portugal: a multicentre cross-sectional study. Health Qual Life Outcomes. 2016;14(1):156.CrossRef Prazeres F, Santiago L. Relationship between health-related quality of life, perceived family support and unmet health needs in adult patients with multimorbidity attending primary care in Portugal: a multicentre cross-sectional study. Health Qual Life Outcomes. 2016;14(1):156.CrossRef
48.
go back to reference Brettschneider C, Leicht H, Bickel H, Dahlhaus A, Fuchs A, Gensichen J, Maier W, Group MS. Relative impact of multimorbid chronic conditions on health-related quality of life--results from the MultiCare cohort study. PLoS One. 2013;8(6):e66742.CrossRef Brettschneider C, Leicht H, Bickel H, Dahlhaus A, Fuchs A, Gensichen J, Maier W, Group MS. Relative impact of multimorbid chronic conditions on health-related quality of life--results from the MultiCare cohort study. PLoS One. 2013;8(6):e66742.CrossRef
Metadata
Title
Measurement of health-related quality by multimorbidity groups in primary health care
Authors
Magdalena Millá-Perseguer
Natividad Guadalajara-Olmeda
David Vivas-Consuelo
Ruth Usó-Talamantes
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2019
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-018-1063-z

Other articles of this Issue 1/2019

Health and Quality of Life Outcomes 1/2019 Go to the issue